The Impact of Introducing Successive Biosimilars on Changes in Prices of Adalimumab, Infliximab, and Trastuzumab-Polish Experiences.
International journal of environmental research and public health/International journal of environmental research and public health（2021）
关键词
biosimilar,health policy,reimbursement,health expenditure,public health,adalimumab,infliximab,trastuzumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要